Global Meningococcal Infections Vaccine Market Growth (Status and Outlook) 2025-2031

September 2025 | 77 pages | ID: GCFE096A8B7EN
LP Information

Abstracts

According to this study, the global Meningococcal Infections Vaccine market size will reach US$ 731 million by 2031.

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in a decrease in meningitis and sepsis among populations where they are widely used.They are given either by injection into a muscle or just under the skin.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Meningococcal Infections Vaccine Industry Forecast” looks at past sales and reviews total world Meningococcal Infections Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Meningococcal Infections Vaccine sales for 2025 through 2031. With Meningococcal Infections Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meningococcal Infections Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Meningococcal Infections Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Meningococcal Infections Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Meningococcal Infections Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meningococcal Infections Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meningococcal Infections Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Infections Vaccine market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Bivalent
• Quadrivalent

Segmentation by Application:

• Group A Meningococcal Bacterial Infections
• Group C Meningococcal Bacterial Infectio

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Sinopharm
• CanSino Biologics
• Zhi Fei Biological

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Meningococcal Infections Vaccine Market Size (2020-2031)
  2.1.2 Meningococcal Infections Vaccine Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Meningococcal Infections Vaccine by Country/Region (2020, 2024 & 2031)
2.2 Meningococcal Infections Vaccine Segment by Type
  2.2.1 Bivalent
  2.2.2 Quadrivalent
2.3 Meningococcal Infections Vaccine Market Size by Type
  2.3.1 Meningococcal Infections Vaccine Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Meningococcal Infections Vaccine Market Size Market Share by Type (2020-2025)
2.4 Meningococcal Infections Vaccine Segment by Application
  2.4.1 Group A Meningococcal Bacterial Infections
  2.4.2 Group C Meningococcal Bacterial Infectio
2.5 Meningococcal Infections Vaccine Market Size by Application
  2.5.1 Meningococcal Infections Vaccine Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Meningococcal Infections Vaccine Market Size Market Share by Application (2020-2025)

3 MENINGOCOCCAL INFECTIONS VACCINE MARKET SIZE BY PLAYER

3.1 Meningococcal Infections Vaccine Market Size Market Share by Player
  3.1.1 Global Meningococcal Infections Vaccine Revenue by Player (2020-2025)
  3.1.2 Global Meningococcal Infections Vaccine Revenue Market Share by Player (2020-2025)
3.2 Global Meningococcal Infections Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MENINGOCOCCAL INFECTIONS VACCINE BY REGION

4.1 Meningococcal Infections Vaccine Market Size by Region (2020-2025)
4.2 Global Meningococcal Infections Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Meningococcal Infections Vaccine Market Size Growth (2020-2025)
4.4 APAC Meningococcal Infections Vaccine Market Size Growth (2020-2025)
4.5 Europe Meningococcal Infections Vaccine Market Size Growth (2020-2025)
4.6 Middle East & Africa Meningococcal Infections Vaccine Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Meningococcal Infections Vaccine Market Size by Country (2020-2025)
5.2 Americas Meningococcal Infections Vaccine Market Size by Type (2020-2025)
5.3 Americas Meningococcal Infections Vaccine Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Meningococcal Infections Vaccine Market Size by Region (2020-2025)
6.2 APAC Meningococcal Infections Vaccine Market Size by Type (2020-2025)
6.3 APAC Meningococcal Infections Vaccine Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Meningococcal Infections Vaccine Market Size by Country (2020-2025)
7.2 Europe Meningococcal Infections Vaccine Market Size by Type (2020-2025)
7.3 Europe Meningococcal Infections Vaccine Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Meningococcal Infections Vaccine by Region (2020-2025)
8.2 Middle East & Africa Meningococcal Infections Vaccine Market Size by Type (2020-2025)
8.3 Middle East & Africa Meningococcal Infections Vaccine Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MENINGOCOCCAL INFECTIONS VACCINE MARKET FORECAST

10.1 Global Meningococcal Infections Vaccine Forecast by Region (2026-2031)
  10.1.1 Global Meningococcal Infections Vaccine Forecast by Region (2026-2031)
  10.1.2 Americas Meningococcal Infections Vaccine Forecast
  10.1.3 APAC Meningococcal Infections Vaccine Forecast
  10.1.4 Europe Meningococcal Infections Vaccine Forecast
  10.1.5 Middle East & Africa Meningococcal Infections Vaccine Forecast
10.2 Americas Meningococcal Infections Vaccine Forecast by Country (2026-2031)
  10.2.1 United States Market Meningococcal Infections Vaccine Forecast
  10.2.2 Canada Market Meningococcal Infections Vaccine Forecast
  10.2.3 Mexico Market Meningococcal Infections Vaccine Forecast
  10.2.4 Brazil Market Meningococcal Infections Vaccine Forecast
10.3 APAC Meningococcal Infections Vaccine Forecast by Region (2026-2031)
  10.3.1 China Meningococcal Infections Vaccine Market Forecast
  10.3.2 Japan Market Meningococcal Infections Vaccine Forecast
  10.3.3 Korea Market Meningococcal Infections Vaccine Forecast
  10.3.4 Southeast Asia Market Meningococcal Infections Vaccine Forecast
  10.3.5 India Market Meningococcal Infections Vaccine Forecast
  10.3.6 Australia Market Meningococcal Infections Vaccine Forecast
10.4 Europe Meningococcal Infections Vaccine Forecast by Country (2026-2031)
  10.4.1 Germany Market Meningococcal Infections Vaccine Forecast
  10.4.2 France Market Meningococcal Infections Vaccine Forecast
  10.4.3 UK Market Meningococcal Infections Vaccine Forecast
  10.4.4 Italy Market Meningococcal Infections Vaccine Forecast
  10.4.5 Russia Market Meningococcal Infections Vaccine Forecast
10.5 Middle East & Africa Meningococcal Infections Vaccine Forecast by Region (2026-2031)
  10.5.1 Egypt Market Meningococcal Infections Vaccine Forecast
  10.5.2 South Africa Market Meningococcal Infections Vaccine Forecast
  10.5.3 Israel Market Meningococcal Infections Vaccine Forecast
  10.5.4 Turkey Market Meningococcal Infections Vaccine Forecast
10.6 Global Meningococcal Infections Vaccine Forecast by Type (2026-2031)
10.7 Global Meningococcal Infections Vaccine Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Meningococcal Infections Vaccine Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Meningococcal Infections Vaccine Product Offered
  11.1.3 Pfizer Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Sinopharm
  11.2.1 Sinopharm Company Information
  11.2.2 Sinopharm Meningococcal Infections Vaccine Product Offered
  11.2.3 Sinopharm Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Sinopharm Main Business Overview
  11.2.5 Sinopharm Latest Developments
11.3 CanSino Biologics
  11.3.1 CanSino Biologics Company Information
  11.3.2 CanSino Biologics Meningococcal Infections Vaccine Product Offered
  11.3.3 CanSino Biologics Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 CanSino Biologics Main Business Overview
  11.3.5 CanSino Biologics Latest Developments
11.4 Zhi Fei Biological
  11.4.1 Zhi Fei Biological Company Information
  11.4.2 Zhi Fei Biological Meningococcal Infections Vaccine Product Offered
  11.4.3 Zhi Fei Biological Meningococcal Infections Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Zhi Fei Biological Main Business Overview
  11.4.5 Zhi Fei Biological Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Meningococcal Infections Vaccine Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Meningococcal Infections Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Bivalent
Table 4. Major Players of Quadrivalent
Table 5. Meningococcal Infections Vaccine Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Meningococcal Infections Vaccine Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Meningococcal Infections Vaccine Market Size Market Share by Type (2020-2025)
Table 8. Meningococcal Infections Vaccine Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Meningococcal Infections Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Meningococcal Infections Vaccine Market Size Market Share by Application (2020-2025)
Table 11. Global Meningococcal Infections Vaccine Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Meningococcal Infections Vaccine Revenue Market Share by Player (2020-2025)
Table 13. Meningococcal Infections Vaccine Key Players Head office and Products Offered
Table 14. Meningococcal Infections Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Meningococcal Infections Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Meningococcal Infections Vaccine Market Size Market Share by Region (2020-2025)
Table 19. Global Meningococcal Infections Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Meningococcal Infections Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Meningococcal Infections Vaccine Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Meningococcal Infections Vaccine Market Size Market Share by Country (2020-2025)
Table 23. Americas Meningococcal Infections Vaccine Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Meningococcal Infections Vaccine Market Size Market Share by Type (2020-2025)
Table 25. Americas Meningococcal Infections Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Meningococcal Infections Vaccine Market Size Market Share by Application (2020-2025)
Table 27. APAC Meningococcal Infections Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Meningococcal Infections Vaccine Market Size Market Share by Region (2020-2025)
Table 29. APAC Meningococcal Infections Vaccine Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Meningococcal Infections Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Meningococcal Infections Vaccine Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Meningococcal Infections Vaccine Market Size Market Share by Country (2020-2025)
Table 33. Europe Meningococcal Infections Vaccine Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Meningococcal Infections Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Meningococcal Infections Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Meningococcal Infections Vaccine Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Meningococcal Infections Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Meningococcal Infections Vaccine
Table 39. Key Market Challenges & Risks of Meningococcal Infections Vaccine
Table 40. Key Industry Trends of Meningococcal Infections Vaccine
Table 41. Global Meningococcal Infections Vaccine Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Meningococcal Infections Vaccine Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Meningococcal Infections Vaccine Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Meningococcal Infections Vaccine Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Pfizer Details, Company Type, Meningococcal Infections Vaccine Area Served and Its Competitors
Table 46. Pfizer Meningococcal Infections Vaccine Product Offered
Table 47. Pfizer Meningococcal Infections Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Pfizer Main Business
Table 49. Pfizer Latest Developments
Table 50. Sinopharm Details, Company Type, Meningococcal Infections Vaccine Area Served and Its Competitors
Table 51. Sinopharm Meningococcal Infections Vaccine Product Offered
Table 52. Sinopharm Meningococcal Infections Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Sinopharm Main Business
Table 54. Sinopharm Latest Developments
Table 55. CanSino Biologics Details, Company Type, Meningococcal Infections Vaccine Area Served and Its Competitors
Table 56. CanSino Biologics Meningococcal Infections Vaccine Product Offered
Table 57. CanSino Biologics Meningococcal Infections Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. CanSino Biologics Main Business
Table 59. CanSino Biologics Latest Developments
Table 60. Zhi Fei Biological Details, Company Type, Meningococcal Infections Vaccine Area Served and Its Competitors
Table 61. Zhi Fei Biological Meningococcal Infections Vaccine Product Offered
Table 62. Zhi Fei Biological Meningococcal Infections Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Zhi Fei Biological Main Business
Table 64. Zhi Fei Biological Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Meningococcal Infections Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Meningococcal Infections Vaccine Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Meningococcal Infections Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Meningococcal Infections Vaccine Sales Market Share by Country/Region (2024)
Figure 8. Meningococcal Infections Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Meningococcal Infections Vaccine Market Size Market Share by Type in 2024
Figure 10. Meningococcal Infections Vaccine in Group A Meningococcal Bacterial Infections
Figure 11. Global Meningococcal Infections Vaccine Market: Group A Meningococcal Bacterial Infections (2020-2025) & ($ millions)
Figure 12. Meningococcal Infections Vaccine in Group C Meningococcal Bacterial Infectio
Figure 13. Global Meningococcal Infections Vaccine Market: Group C Meningococcal Bacterial Infectio (2020-2025) & ($ millions)
Figure 14. Global Meningococcal Infections Vaccine Market Size Market Share by Application in 2024
Figure 15. Global Meningococcal Infections Vaccine Revenue Market Share by Player in 2024
Figure 16. Global Meningococcal Infections Vaccine Market Size Market Share by Region (2020-2025)
Figure 17. Americas Meningococcal Infections Vaccine Market Size 2020-2025 ($ millions)
Figure 18. APAC Meningococcal Infections Vaccine Market Size 2020-2025 ($ millions)
Figure 19. Europe Meningococcal Infections Vaccine Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Meningococcal Infections Vaccine Market Size 2020-2025 ($ millions)
Figure 21. Americas Meningococcal Infections Vaccine Value Market Share by Country in 2024
Figure 22. United States Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Meningococcal Infections Vaccine Market Size Market Share by Region in 2024
Figure 27. APAC Meningococcal Infections Vaccine Market Size Market Share by Type (2020-2025)
Figure 28. APAC Meningococcal Infections Vaccine Market Size Market Share by Application (2020-2025)
Figure 29. China Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 33. India Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Meningococcal Infections Vaccine Market Size Market Share by Country in 2024
Figure 36. Europe Meningococcal Infections Vaccine Market Size Market Share by Type (2020-2025)
Figure 37. Europe Meningococcal Infections Vaccine Market Size Market Share by Application (2020-2025)
Figure 38. Germany Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 39. France Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Meningococcal Infections Vaccine Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Meningococcal Infections Vaccine Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Meningococcal Infections Vaccine Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Meningococcal Infections Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 52. APAC Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 53. Europe Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 55. United States Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 56. Canada Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 57. Mexico Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 58. Brazil Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 59. China Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 60. Japan Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 61. Korea Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 63. India Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 64. Australia Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 65. Germany Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 66. France Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 67. UK Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 68. Italy Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 69. Russia Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 70. Egypt Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 71. South Africa Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 72. Israel Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 73. Turkey Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)
Figure 74. Global Meningococcal Infections Vaccine Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Meningococcal Infections Vaccine Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Meningococcal Infections Vaccine Market Size 2026-2031 ($ millions)